FBPixel High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment - David Perlmutter M.D.

Science

Study Title
High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment
Publication
The Netherlands Journal of Medicine
Author(s)

J. Hofstra, S. Loves, B. van Wageningen, J. Ruinemans-Koerts, I. Janssen, H. de Boer

Abstract

Background: Obesity can be associated with biochemical evidence of isolated hypogonadotropic hypogonadism (iHH) in men. Prevalence and severity of iHH in obese men are not exactly known.
Objective: To assess the prevalence of iHH in obese men. design and subjects: Cross-sectional study of 160 obese men, bMi >30 kg/m2, who applied for medical or surgical treatment of obesity in a general teaching hospital.
Main outcome measures: Total and calculated free testosterone (TT and fT) in relation to body mass index (bMi).
Results: Mean age of the study population was 43.3 ± 0.8 years (mean ± sEM), bMi ranged from 30.0 to 65.7 kg/m2. TT and fT levels were inversely related to bMi (-0.48, p

Date
March 12, 2008
View study

Share This

Related Topics

SexObesityCardiovascular DiseaseLibido

Dr. David Perlmutter is on the cutting edge of innovative medicine that looks at all lifestyle influences on health and illness.

Andrew Weil, MD